Radiotherapy cost-calculation and its impact on capacity planning

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 3, Issue 4, 2003, Pages 497-507

  Lievens, Yolande ^a   Slotman, Berend Jan ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Activity based costing; Cancer; Cost calculation; Infrastructure; Planning; Radiotherapy

Indexed keywords

BONE METASTASIS; BREAST CANCER; CALCULATION; CANCER RADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; LUNG CANCER; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; PROSTATE CANCER; REIMBURSEMENT; REVIEW; TREATMENT PLANNING;

EID: 0042061200     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.3.4.497     Document Type: Review

References (42)

1. Van der Schueren E, Kesteloot K, Cleemput I. Federation of European Cancer Societies. Full Report. Economic evaluation in cancer care: questions and answers on how to alleviate conflicts between rising needs and expectations and tightening budgets. Eur. J. Cancer 36, 13-36 (2000).
2. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford University Press, NY, USA (1996).
3. Boyle P, Veronesi U, Tubiana M et al. European School of Oncology advisory report to the European Commission for the Europe Against Cancer Program. European Code Against Cancer. Eur J. Cancer 31A, 1395-1405 (1995).
4. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur. J. Cancer 33, 1075-1107 (1997).
5. SBU. Cost of Radiotherapy in Sweden. Acta Oncol. 6(Suppl.), 57-71 (1996).
6. Postma TJ, Terpstra S. Long range healthcare capacity planning in the Netherlands. The case of radiotherapy. Eur. J. Health Econom. 3, 251-260 (2002).
7. Slotman BJ, Leer JWH. Infrastructure of radiotherapy in the Netherlands: evaluation of prognoses and introduction of a new model for determining the needs. Radiother. Oncol. (In Press).
8. Van den Bogaert W, van der Schueren E. Lokale tumorcontrole, basis voor curatie in de oncologie: effect van bestraling op klierstreken bij borstkanker. Tijdschr. Geneesk. 54(13), 897-905 (1998).
9. Chow E, Danjoux C, Wong R et al. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. Radiother. Oncol. 56, 305-314 (2000).
10. Dawson R, Currow D, Stevens G et al. Radiotherapy for bone metastases: a critical appraisal of outcome measures. J. Pain Symp. Control 17, 208-218 (1999).
11. Koopmanschap M, van Roijen L, Bonneux L et al. Current and future costs of cancer. Eur. J. Cancer 30A, 60-65 (1994).
12. Peters LJ. Through a glass darkly: predicting the future of radiation oncology. Int. J. Radiat. Oncol. Biol. Phys. 31(2), 219-225 (1995).
13. Van Roijen L, Koopmanschap MA, Bonneux L. Kosten van ziekten. Ned. Tijdschrift. Geneesk. 136, 74-80 (1992).
14. Neymark N. Assessing the Economic Value of AntiCancer Therapies. Recent Results in Cancer Research. Springer-Verlag, Berlin-Heidelberg, Germany (1998).
15. Van daal WAJ, Bos MA. Infrastructure for radiotherapy in the Netherlands: development from 1970 to 2010. Int. J. Radiat. Oncol. Biol. Phys. 2, 411-415 (1997).
16. Goddard M, Hutton J. Economic evaluation of trends in cancer therapy. Marginal or average costs? Int. J. Technol. Asses. Healthcare 7, 594-603 (1991).
17. Goddard M, Maher EJ, Hutton J et al. Palliative radiotherapy - counting the costs of changing practice. Health Policy 17, 243-256 (1991).
18. Penn CR, Megavoltage irradiation in a district general hospital remote from a main oncology center: the Torbay experience. Clin. Oncol. R. Coll. Radiol. 4(2), 108-113 (1992).
19. Van den Bogaert W. The material infrastructure of the radiotherapy departments in Belgium. Commission for material infrastructure of the Belgian Society of Radiotherapy and Oncology (BVRO-ABRO) (1983).
20. Wodinsky HB, Jenkin RDT. The cost of radiation treatment at an Ontario regional cancer center. Can. Med. Ass. J. 137, 906-909 (1987).
21. Earle C, Coyle D, Smith A et al. The cost of radiotherapy at an Ontario regional cancer center: a re-evaluation. Crit. Rev. Oncol. Hematol. 2, 87-93 (1999).
22. Weinstein MC, Siegel JE, Gold MR et al. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. J. Am. Med. Ass. 276, 1253-1258 (1996).
23. Lievens Y, Van den Bogaert W, Rijders A et al. Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system? Radiother. Oncol. 56, 287-293 (2000).
24. Finkler SA. The distinction between costs and charges. Ann. Int. Med. 96(1), 102-109 (1982).
25. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Healthcare Programs. Second Edition. Oxford University Press, Oxford, UK (1997).
26. Perez CA, Kobeissi B, Smith BD et al. Cost accounting in radiation oncology: a computer-based model for reimbursement. Int. J. Radiat. Oncol. Biol, Phys. 25 (5), 895-906 (1993).
27. Baker JJ. Activity-Based Costing and Activity-Based Management for Healthcare. Aspen Publishers, Gaithersburg, MD, USA (1998).
28. Azoury E. L'Activity based costing: application au secteur medico-technique de la radiothérapie des Cliniques Universitaires Saint-Luc. Université Catholique de Louvain, Faculté de Médecine, Ecole de Santé Public. (1999-2000).
29. Valiquette L, Dunscombe P. The Economic Characterisation of Radiation Treatment Process within a Cancer Care Program. Proceedings of the 7th Canadian Conference on Health Economics. Swan WR, Taylor P (Eds). Carleton University, Ottowa, Canada, 349-360 (1997).
30. Cooper R. The rise of activity-based costing - part one: what is an activity-based cost system? J. Cost Management Summer, 45-54 (1988).
31. Cooper R. The rise of activity-based costing - part two: when do I need an activity-based cost system? J. Cost Management Fall, 41-48 (1988).
32. Lievens Y, Van den Bogaert W, Kesteloo K Activity-based costing: a practical model for cost calculation in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. (2003) (In Press),
33. Kesteloot K, Lievens Y, van der Schueren E. Improved management of radiotherapy departments through accurate cost data. Radiother. Oncol. 55, 251-262 (2000).
34. Dixon P, Mackillop W. Could changes in clinical practice reduce waiting lists for radiotherapy? J. Health Serv. Res. Policy. 6(2), 70-77 (2001).
35. Dunscombe P, Roberts G. An economic framework for evaluating a multileaf collimator. Int. J. Technol. Assess. Healthcare. 16, 242-250 (2000).
36. Smith RD, Jan S, Shiell A. Efficiency considerations ion the expansion of radiation therapy services. Int. J. Radiat. Oncol. Biol Phys. 31(2), 379-385 (1995).
37. Dunscombe P, Roberts G, Walker J. The cost of radiotherapy as a function of facility size and hours of operation. Br. J. Radiol. 72, 598-603 (1999).
38. Routsis D, Thomas S. Are extended working days sustainable in radiotherapy? J. Radiother. Pract. (In Press).
39. Dunscombe P, Roberts G. Radiation service delivery models for a dispersed patient population. Clin. Oncol. 13, 29-37 (2001).
40. Roberts GH, Dunscombe PB, Samant RS. Geographic delivery models for radiotherapy services. Austral. Radiol. 46, 290-294 (2002).
41. Gezondheidsraad, Ontwikkelingen in de radiotherapie. Den Haag: Gezondheidsraad (1993).
42. Radiotherapie: onze zorg. Actualisatiecommissie Dutch Society for Radiation Oncology. NVRO. Utrecht, The Netherlands (1999).